On this episode of the ILTV News Podcast, host Maayan Hoffman sits down with Mati Gill, CEO of AION Labs, to explore how artificial intelligence is revolutionizing drug discovery—and how Israel is positioning itself at the center of it all. From launching biotech startups with global pharma giants to surviving rocket fire while building the future of medicine, Gill shares how AION Labs is accelerating drug development and why Israel could become the next big hub for biotech.
